AbbVie Inc.
Methods and compositions for treating asthma using anti-IL-13 antibodies
Last updated:
Abstract:
The invention provides methods and compositions for treating asthma, e.g., mild or moderate asthma, in a subject using an anti-IL-13 antibody, or antigen-binding portion thereof.
Status:
Grant
Type:
Utility
Filling date:
27 Jun 2017
Issue date:
16 Feb 2021